ORIGINAL RESEARCH
Accepted on 08 Oct 2025
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models
doi 10.3389/fphar.2025.1692250
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Emerging Targeted and Immunotherapeutic Strategies in Oncology: From Solid Tumors to Hematologic Malignancies
Emerging Targeted and Immunotherapeutic Strategies in Oncology: From Solid Tumors to Hematologic Malignancies
1,493
Total downloads
9,347
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 15 Sep 2025
Breaking the cancer code: a novel DNA minicircle to disable STAT3 in ovarian cancer cells SKOV3
doi 10.3389/fphar.2025.1673427
- 1,091 views
ORIGINAL RESEARCH
Published on 12 Sep 2025
A novel cytotoxic anti-B7-H3 affibody with therapeutic potential in acute myeloid leukemia
doi 10.3389/fphar.2025.1684226
- 1,409 views
ORIGINAL RESEARCH
Published on 15 Aug 2025
Global research trends on ALK-TKIs in non-small cell lung cancer: a bibliometric analysis
doi 10.3389/fphar.2025.1665174
- 1,343 views
CASE REPORT
Published on 13 Aug 2025
Case Report: Ocular metastasis from ALK-rearranged pulmonary adenocarcinoma presenting as a pseudo-syndrome of anterior uveitis
doi 10.3389/fonc.2025.1619667
- 878 views
REVIEW
Published on 08 Aug 2025
Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications
doi 10.3389/fimmu.2025.1634157
- 1,073 views
ORIGINAL RESEARCH
Published on 29 Jul 2025
Cadonilimab in combination with chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis
doi 10.3389/fphar.2025.1646818
- 1,343 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.